Msc-and exosome-based immunotherapy

Aharon Brodie (Inventor), Chaya Brodie (Inventor)

Research output: Patent

Abstract

Compositions comprising at least one of miR that down regulates PD-L1/PD-1, MSCs expressing same, or exosomes from those MSCs are provided. Methods of decreasing PD-L1 expression, PD-1 expression or both and treating PD-L1 positive cancers using same are also provided.
Original languageEnglish
Patent numberUS20210260141A1
StatePublished - 26 Aug 2021

Fingerprint

Dive into the research topics of 'Msc-and exosome-based immunotherapy'. Together they form a unique fingerprint.

Cite this